New Science Ventures, LLC
New Science Ventures, LLC (NSV) is a venture capital firm based in Connecticut and London. The firm invests in early and late-stage companies that employ novel scientific approaches to address significant unmet needs in the life sciences and information technology sectors. NSV focuses on creating value through breakthrough science, leveraging its extensive experience and networks in these industries.
New Science Ventures, LLC
500 West Putnam Avenue, Suite 400, Greenwich CT 06830
Portfolio
Developing novel strategies to treat metabolic, cholestatic, and fibrotic diseases. Announced positive results from Phase 2b ICONA clinical trial of icosabutate in biopsy-confirmed F1-F3 MASH.
#Biotechnology
Focused on developing innovative oral therapies for autoimmune, inflammatory, and neurodegenerative diseases. Announced data from Phase 2 trial of TYK2 inhibitor VTX958 in Crohn’s disease.
#Biopharmaceutical
Leader in advanced in-space propulsion design and manufacturing. Announced the first close of its Series C funding round.
#Space Propulsion
Specializes in regenerative medicine. Announced approval from the FDA for its allogenic bone grafting material NVDX3 to enter an investigational new drug study.
#Biotechnology
Unveiled a groundbreaking advanced analog in-memory compute architecture addressing power/performance/price and environmental sustainability in AI inferencing.
#Artificial Intelligence